Fresenius SE & Co KGaA ADR (FSNUY)
Fresenius SE & Co KGaA ADR is a depositary receipt representing common stock of Fresenius SE & Co. KGaA, a healthcare company based in Bad Homburg vor der Höhe, Germany. Through its Fresenius Kabi and Fresenius Helios segments, the issuer serves chronically and critically ill patients across North America, Europe, the Asia-Pacific region, Latin America, and Africa. Fresenius Kabi focuses on therapies and care products, including biopharmaceuticals, clinical nutrition, medical technology, intravenous generic medicines, IV fluids, biosimilars, and a range of enteral and parenteral nutrition products. Its medical technology portfolio includes disposables, infusion pumps, apheresis machines, and cell therapy devices. Fresenius Helios operates hospitals, medical care centers, occupational health centers, prevention centers, outpatient health centers, and diagnostic services. Founded in 1912, the company adopted its current name in January 2011.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
OTC-FSNU.Y
|
$14.47
|
15.7% Upside
|
Fair
|
$15.91
|
27.2% Upside
|
Undervalued
|
Great
|
—
|
—
|
0.2
|
1.6%
|
August 5, 2026
|
16.0x
|
1.2x
|
1.1x
|
27.663 B
|
36.975 B
|
32.3%
|
72.9%
|
7.4
|
31.8%
|
119.5%
|
